Poly(Adenosine Diphosphate-Ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor

Pathology and Oncology Research

Volumn 15, Issue 1, 2009, Pages 47-53

  Csete, Béla ^a   Lengyel, Zsuzsanna ^a   Kádár, Zsolt ^a   Battyáni, Zita ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Kaposi Mor Teaching Hospital   (Hungary)

Author keywords

Cutaneous malignant melanoma; Immunohistochemistry; Poly(ADP ribose) polymerase 1

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINOCYTES; LYMPHATIC METASTASIS; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLY(ADP-RIBOSE) POLYMERASES; PREGNANCY; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 67749099823     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9086-0     Document Type: Article

References (17)

1. JC Ame C Spenkehauer G de Murcia 2004 The PARP superfamily Bioessays 26 882 893
2. X Wang K Ohnishi A Takahasi 1998 Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation Oncogene 17 2819 2825
3. WA Muller M Erlanger 1994 Malignant melanoma in life insurance-thickness or anatomic layer? Versicherungsmedizin 46 193 195
4. U Keilholz P Martus CJ Punt 2002 Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin Eur J Cancer 38 1501 1511
5. C Jansen 1995 Effect of sunlight on the skin-what have we learned? Nord Med 110 85 87
6. MD Vodenicharov MM Ghodgaonkar SS Halappanavar 2005 Mechanism of early biphasic activation of poly(ADP-ribose) polymerase-1 in response to ultraviolet B radiation J Cell Sci 118 589 599
7. S Staibano S Pepe L Muzio 2005 Poly(adenosine diphosphate-ribose) polymerase-1 expression in malignant melanomas from photoexposed areas of the head and neck region Human Pathol 36 724 731
8. CM Balch AC Buzaid MB Atkins 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648
9. M Masutani H Nakagama T Sugimura 2005 Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease Cell Mol Life Sci 62 769 783
10. JJ van den Oord N Vandeghinste M De Ley 1994 Bcl-2 expression in human melanocytes and melanocytic tumors Am J Pathol 145 294 300
11. LH Boise M Gonzalez-Garcia CE Postema 1993 Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Cell 74 597 608
12. H Steller 1995 Mechanisms and genes of cellular suicide Science 267 1445 1449
13. L Tang VA Tron JC Reed 1998 Expression of apoptosis regulators in cutaneous malignant melanoma Clin Cancer Res 4 1865 1871
14. H Helmbach MA Kern E Rossmann 2002 Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency J Invest Dermatol 118 923 932
15. W Feleszko I Mlynarczuk D Olszewska 2002 Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism Int J Cancer 100 111 118
16. A Vaculova J Hofmanova K Soucek 2002 Tumor necrosis factor-alpha induces apoptosis associated with poly(ADP-ribose) polymerase cleavage in HT-29 colon cancer cells Anticancer Res 22 1635 1639
17. EQ Shyong Y Lu A Lazinsky 2002 Effects of the isoflavone 4V,5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage Carcinogenesis 23 317 321